{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:16:27Z","timestamp":1790691387487,"version":"4.1.0"},"reference-count":151,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mutations in<jats:italic>ASAH1<\/jats:italic>have been linked to two allegedly distinct disorders: Farber disease (FD) and spinal muscular atrophy with progressive myoclonic epilepsy (SMA-PME). We have previously reported FD-like phenotypes in mice harboring a single amino acid substitution in acid ceramidase (ACDase), P361R, known to be pathogenic in humans (P361R-Farber). Here we describe a mouse model with an SMA-PME-like phenotype (P361R-SMA). P361R-SMA mice live 2-3-times longer than P361R-Farber mice and have different phenotypes including progressive ataxia and bladder dysfunction, which suggests neurological dysfunction. We found profound demyelination, loss of axons, and altered sphingolipid levels in P361R-SMA spinal cords; severe pathology was restricted to the white matter. Our model can serve as a tool to study the pathological effects of ACDase deficiency on the central nervous system and to evaluate potential therapies for SMA-PME.<\/jats:p>","DOI":"10.1038\/s42003-023-04932-w","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T14:03:36Z","timestamp":1685023416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Spinal muscular atrophy-like phenotype in a mouse model of acid ceramidase deficiency"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4877-6241","authenticated-orcid":false,"given":"Murtaza S.","family":"Nagree","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitka","family":"Rybova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4878-5711","authenticated-orcid":false,"given":"Annie","family":"Kleynerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carissa J.","family":"Ahrenhoerster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer T.","family":"Saville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TianMeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxwell","family":"Bachochin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"McKillop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Lawlor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6612-1062","authenticated-orcid":false,"given":"Alexey V.","family":"Pshezhetsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0587-6322","authenticated-orcid":false,"given":"Olena","family":"Isaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Budde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9092-8942","authenticated-orcid":false,"given":"Maria","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8165-8995","authenticated-orcid":false,"given":"Jeffrey A.","family":"Medin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,25]]},"reference":[{"key":"4932_CR1","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1016\/S0021-9258(18)51879-2","volume":"238","author":"S Gatt","year":"1963","unstructured":"Gatt, S. Enzymic hydrolysis and synthesis of ceramides. J. Biol. Chem. 238, 3131\u20133133 (1963).","journal-title":"J. Biol. Chem."},{"key":"4932_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1006\/geno.1999.5940","volume":"62","author":"CM Li","year":"1999","unstructured":"Li, C. M. et al. The human acid ceramidase gene (ASAH): structure, chromosomal location, mutation analysis, and expression. Genomics 62, 223\u2013231 (1999).","journal-title":"Genomics"},{"key":"4932_CR3","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1042\/EBC20190090","volume":"64","author":"M van Eijk","year":"2020","unstructured":"van Eijk, M., Ferraz, M. J., Boot, R. G. & Aerts, J. Lyso-glycosphingolipids: presence and consequences. Essays Biochem 64, 565\u2013578 (2020).","journal-title":"Essays Biochem"},{"key":"4932_CR4","doi-asserted-by":"publisher","first-page":"158972","DOI":"10.1016\/j.bbalip.2021.158972","volume":"1866","author":"K Tsuboi","year":"2021","unstructured":"Tsuboi, K. et al. Involvement of acid ceramidase in the degradation of bioactive N-acylethanolamines. Biochimica et. Biophysica Acta (BBA) - Mol. Cell Biol. Lipids 1866, 158972 (2021).","journal-title":"Biochimica et. Biophysica Acta (BBA) - Mol. Cell Biol. Lipids"},{"key":"4932_CR5","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1126\/science.178.4065.1100","volume":"178","author":"M Sugita","year":"1972","unstructured":"Sugita, M., Dulaney, J. T. & Moser, H. W. Ceramidasedeficiency in Farber\u2019s disease (lipogranulomatosis). Science 178, 1100\u20131102 (1972).","journal-title":"Science"},{"key":"4932_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0009-8981(94)05970-4","volume":"234","author":"T Fujiwaki","year":"1995","unstructured":"Fujiwaki, T. et al. Tissue accumulation of sulfatide and GM3 ganglioside in a patient with variant Farber disease. Clin. Chim. Acta 234, 23\u201336 (1995).","journal-title":"Clin. Chim. Acta"},{"key":"4932_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0845-z","volume":"13","author":"FPS Yu","year":"2018","unstructured":"Yu, F. P. S., Amintas, S., Levade, T. & Medin, J. A. Acid ceramidase deficiency: Farber disease and SMA-PME. Orphanet J. Rare Dis. 13, 121 (2018).","journal-title":"Orphanet J. Rare Dis."},{"key":"4932_CR8","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1002\/humu.24056","volume":"41","author":"SH Elsea","year":"2020","unstructured":"Elsea, S. H. et al. ASAH1 pathogenic variants associated with acid ceramidase deficiency: Farber disease and spinal muscular atrophy with progressive myoclonic epilepsy. Hum. Mutat. 41, 1469\u20131487 (2020).","journal-title":"Hum. Mutat."},{"key":"4932_CR9","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/BF00714300","volume":"16","author":"A Fiumara","year":"1993","unstructured":"Fiumara, A., Nigro, F., Pavone, L. & Moser, H. W. Farber disease with prolonged survival. J. Inherit. Metab. Dis. 16, 915\u2013916 (1993).","journal-title":"J. Inherit. Metab. Dis."},{"key":"4932_CR10","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/jmd2.12008","volume":"46","author":"C Goudie","year":"2019","unstructured":"Goudie, C. et al. Hematopoietic stem cell transplant does not prevent neurological deterioration in infants with Farber disease: Case report and literature review. JIMD Rep. 46, 46\u201351 (2019).","journal-title":"JIMD Rep."},{"key":"4932_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ajhg.2012.05.001","volume":"91","author":"J Zhou","year":"2012","unstructured":"Zhou, J. et al. Spinal muscular atrophy associated with progressive myoclonic epilepsy is caused by mutations in ASAH1. Am. J. Hum. Genet 91, 5\u201314 (2012).","journal-title":"Am. J. Hum. Genet"},{"key":"4932_CR12","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1684\/epd.2016.0858","volume":"18","author":"T Haluk","year":"2016","unstructured":"Haluk, T. & Judith, M. Spinal muscular atrophy associated with progressive myoclonus epilepsy. Epileptic Disord. 18, 128\u2013134 (2016).","journal-title":"Epileptic Disord."},{"key":"4932_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2147\/IMCRJ.S202046","volume":"12","author":"R Shervin Badv","year":"2019","unstructured":"Shervin Badv, R., Nilipour, Y., Rahimi-Dehgolan, S., Rashidi-Nezhad, A. & Ghahvechi Akbari, M. A novel case report of spinal muscular atrophy with progressive myoclonic epilepsy from Iran. Int Med Case Rep. J. 12, 155\u2013159 (2019).","journal-title":"Int Med Case Rep. J."},{"key":"4932_CR14","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1038\/ejhg.2016.28","volume":"24","author":"M Filosto","year":"2016","unstructured":"Filosto, M. et al. ASAH1 variant causing a mild SMA phenotype with no myoclonic epilepsy: a clinical, biochemical and molecular study. Eur. J. Hum. Genet 24, 1578\u20131583 (2016).","journal-title":"Eur. J. Hum. Genet"},{"key":"4932_CR15","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/epi.12977","volume":"56","author":"G Rubboli","year":"2015","unstructured":"Rubboli, G. et al. Spinal muscular atrophy associated with progressive myoclonic epilepsy: A rare condition caused by mutations in ASAH1. Epilepsia 56, 692\u2013698 (2015).","journal-title":"Epilepsia"},{"key":"4932_CR16","doi-asserted-by":"publisher","first-page":"e20161068","DOI":"10.1542\/peds.2016-1068","volume":"138","author":"HL Teoh","year":"2016","unstructured":"Teoh, H. L. et al. Polyarticular arthritis and spinal muscular atrophy in acid ceramidase deficiency. Pediatrics 138, e20161068 (2016).","journal-title":"Pediatrics"},{"key":"4932_CR17","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41431-018-0250-z","volume":"27","author":"N Ame van der Beek","year":"2019","unstructured":"Ame van der Beek, N. et al. A new case of SMA phenotype without epilepsy due to biallelic variants in ASAH1. Eur. J. Hum. Genet 27, 337\u2013339 (2019).","journal-title":"Eur. J. Hum. Genet"},{"key":"4932_CR18","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/ana.410060309","volume":"6","author":"J Jankovic","year":"1979","unstructured":"Jankovic, J. & Rivera, V. M. Hereditary myoclonus and progressive distal muscular atrophy. Ann. Neurol. 6, 227\u2013231 (1979).","journal-title":"Ann. Neurol."},{"key":"4932_CR19","first-page":"141","volume":"20","author":"JW Lance","year":"1984","unstructured":"Lance, J. W. & Evans, W. A. Progressive myoclonic epilepsy, nerve deafness and spinal muscular atrophy. Clin. Exp. Neurol. 20, 141\u2013151 (1984).","journal-title":"Clin. Exp. Neurol."},{"key":"4932_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/1755-7682-7-42","volume":"7","author":"DS Liyanage","year":"2014","unstructured":"Liyanage, D. S., Pathberiya, L. S., Gooneratne, I. K., Vithanage, K. K. & Gamage, R. Association of type IV spinal muscular atrophy (SMA) with myoclonic epilepsy within a single family. Int. Arch. Med. 7, 42 (2014).","journal-title":"Int. Arch. Med."},{"key":"4932_CR21","first-page":"201","volume":"60","author":"M Taglioli","year":"1990","unstructured":"Taglioli, M., Bartolini, S., Volpi, G., Alberti, G. & Ambrosetto, G. [Progressive familial myoclonic epilepsy with bulbo-spinal amyotrophy. Clinical, electrophysiological study, and biopsy of a case]. Riv. Neurol. 60, 201\u2013206 (1990).","journal-title":"Riv. Neurol."},{"key":"4932_CR22","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.nmd.2014.11.007","volume":"25","author":"BG Gir\u00e1ldez","year":"2015","unstructured":"Gir\u00e1ldez, B. G. et al. Uniparental disomy as a cause of spinal muscular atrophy and progressive myoclonic epilepsy: Phenotypic homogeneity due to the homozygous c.125C>T mutation in ASAH1. Neuromuscul. Disord. 25, 222\u2013224 (2015).","journal-title":"Neuromuscul. Disord."},{"key":"4932_CR23","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/cge.12307","volume":"86","author":"DA Dyment","year":"2014","unstructured":"Dyment, D. A. et al. Evidence for clinical, genetic and biochemical variability in spinal muscular atrophy with progressive myoclonic epilepsy. Clin. Genet. 86, 558\u2013563 (2014).","journal-title":"Clin. Genet."},{"key":"4932_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre, S. et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80, 155\u2013165 (1995).","journal-title":"Cell"},{"key":"4932_CR25","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/archneurol.2011.74","volume":"68","author":"SJ Kolb","year":"2011","unstructured":"Kolb, S. J. & Kissel, J. T. Spinal muscular atrophy: a timely review. Arch. Neurol. 68, 979\u2013984 (2011).","journal-title":"Arch. Neurol."},{"key":"4932_CR26","doi-asserted-by":"publisher","first-page":"101618","DOI":"10.1016\/j.nicl.2018.101618","volume":"21","author":"G Querin","year":"2019","unstructured":"Querin, G. et al. The spinal and cerebral profile of adult spinal-muscular atrophy: A multimodal imaging study. NeuroImage: Clin. 21, 101618 (2019).","journal-title":"NeuroImage: Clin."},{"key":"4932_CR27","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.braindev.2012.03.009","volume":"35","author":"T Yonekawa","year":"2013","unstructured":"Yonekawa, T., Komaki, H., Saito, Y., Sugai, K. & Sasaki, M. Peripheral nerve abnormalities in pediatric patients with spinal muscular atrophy. Brain Dev. 35, 165\u2013171 (2013).","journal-title":"Brain Dev."},{"key":"4932_CR28","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.braindev.2011.07.003","volume":"34","author":"AK Chedrawi","year":"2012","unstructured":"Chedrawi, A. K. et al. Novel V97G ASAH1 mutation found in Farber disease patients: unique appearance of the disease with an intermediate severity, and marked early involvement of central and peripheral nervous system. Brain Dev. 34, 400\u2013404 (2012).","journal-title":"Brain Dev."},{"key":"4932_CR29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/BF00544640","volume":"344","author":"G Molz","year":"1968","unstructured":"Molz, G. Farbersche Krankheit. Virchows Arch. A 344, 86\u201399 (1968).","journal-title":"Virchows Arch. A"},{"key":"4932_CR30","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ymgme.2018.08.014","volume":"125","author":"S K\u00f6rver","year":"2018","unstructured":"K\u00f6rver, S., Vergouwe, M., Hollak, C. E. M., van Schaik, I. N. & Langeveld, M. Development and clinical consequences of white matter lesions in Fabry disease: a systematic review. Mol. Genet. Metab. 125, 205\u2013216 (2018).","journal-title":"Mol. Genet. Metab."},{"key":"4932_CR31","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s10545-011-9288-6","volume":"34","author":"EH Davies","year":"2011","unstructured":"Davies, E. H., Seunarine, K. K., Banks, T., Clark, C. A. & Vellodi, A. Brain white matter abnormalities in paediatric Gaucher Type I and Type III using diffusion tensor imaging. J. Inherit. Metab. Dis. 34, 549\u2013553 (2011).","journal-title":"J. Inherit. Metab. Dis."},{"key":"4932_CR32","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1055\/s-2005-865863","volume":"36","author":"M Di Rocco","year":"2005","unstructured":"Di Rocco, M. et al. Different molecular mechanisms leading to white matter hypomyelination in infantile onset lysosomal disorders. Neuropediatrics 36, 265\u2013269 (2005).","journal-title":"Neuropediatrics"},{"key":"4932_CR33","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1148\/rg.2019180081","volume":"39","author":"LL Resende","year":"2019","unstructured":"Resende, L. L., Paiva, A. R. Bd, Kok, F., Leite, Cd. C. & Lucato, L. T. Adult leukodystrophies: A step-by-step diagnostic approach. RadioGraphics 39, 153\u2013168 (2019).","journal-title":"RadioGraphics"},{"key":"4932_CR34","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1096\/fj.06-7016com","volume":"21","author":"E Eliyahu","year":"2007","unstructured":"Eliyahu, E., Park, J.-H., Shtraizent, N., He, X. & Schuchman, E. H. Acid ceramidase is a novel factor required for early embryo survival. FASEB J. 21, 1403\u20131409 (2007).","journal-title":"FASEB J."},{"key":"4932_CR35","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1006\/geno.2002.6686","volume":"79","author":"C-M Li","year":"2002","unstructured":"Li, C.-M. et al. Insertional mutagenesis of the mouse acid ceramidase gene leads to early embryonic lethality in homozygotes and progressive lipid storage disease in heterozygotes. Genomics 79, 218\u2013224 (2002).","journal-title":"Genomics"},{"key":"4932_CR36","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/emmm.201202301","volume":"5","author":"AM Alayoubi","year":"2013","unstructured":"Alayoubi, A. M. et al. Systemic ceramide accumulation leads to severe and varied pathological consequences. EMBO Mol. Med. 5, 827\u2013842 (2013).","journal-title":"EMBO Mol. Med"},{"key":"4932_CR37","doi-asserted-by":"publisher","first-page":"L406","DOI":"10.1152\/ajplung.00223.2017","volume":"314","author":"FPS Yu","year":"2018","unstructured":"Yu, F. P. S. et al. Chronic lung injury and impaired pulmonary function in a mouse model of acid ceramidase deficiency. Am. J. Physiol. Lung Cell Mol. Physiol. 314, L406\u2013L420 (2018).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"4932_CR38","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1038\/s41374-019-0271-4","volume":"99","author":"FPS Yu","year":"2019","unstructured":"Yu, F. P. S. et al. Hepatic pathology and altered gene transcription in a murine model of acid ceramidase deficiency. Lab Invest. 99, 1572\u20131592 (2019).","journal-title":"Lab Invest"},{"key":"4932_CR39","doi-asserted-by":"publisher","first-page":"e162","DOI":"10.3324\/haematol.2014.108530","volume":"100","author":"S Dworski","year":"2015","unstructured":"Dworski, S. et al. Markedly perturbed hematopoiesis in acid ceramidase deficient mice. Haematologica 100, e162\u2013e165 (2015).","journal-title":"Haematologica"},{"key":"4932_CR40","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.ajpath.2016.12.005","volume":"187","author":"J Sikora","year":"2017","unstructured":"Sikora, J. et al. Acid ceramidase deficiency in mice results in a broad range of central nervous system abnormalities. Am. J. Pathol. 187, 864\u2013883 (2017).","journal-title":"Am. J. Pathol."},{"key":"4932_CR41","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.ajpath.2018.10.018","volume":"189","author":"FPS Yu","year":"2019","unstructured":"Yu, F. P. S. et al. Acid ceramidase deficiency in mice leads to severe ocular pathology and visual impairment. Am. J. Pathol. 189, 320\u2013338 (2019).","journal-title":"Am. J. Pathol."},{"key":"4932_CR42","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/jimd.12552","volume":"45","author":"J Rybova","year":"2022","unstructured":"Rybova, J., Kuchar, L., Sikora, J., McKillop, W. M. & Medin, J. A. Skin inflammation and impaired adipogenesis in a mouse model of acid ceramidase deficiency. J. Inherit. Metab. Dis. 45, 1175\u20131190 (2022).","journal-title":"J. Inherit. Metab. Dis."},{"key":"4932_CR43","unstructured":"Dyment, D. A., Bennett, S. A. L., Medin, J. A. & Levade, T. In GeneReviews((R)) (eds M. P. Adam et al.) (2018)."},{"key":"4932_CR44","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1038\/s41598-018-20052-6","volume":"8","author":"FPS Yu","year":"2018","unstructured":"Yu, F. P. S., Dworski, S. & Medin, J. A. Deletion of MCP-1 impedes pathogenesis of acid ceramidase deficiency. Sci. Rep. 8, 1808\u20131808 (2018).","journal-title":"Sci. Rep."},{"key":"4932_CR45","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1515\/hsz-2018-0170","volume":"399","author":"N Beckmann","year":"2018","unstructured":"Beckmann, N. et al. Pathological manifestations of Farber disease in a new mouse model. Biol. Chem. 399, 1183\u20131202 (2018).","journal-title":"Biol. Chem."},{"key":"4932_CR46","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0960-9822(98)70254-4","volume":"8","author":"A Nagy","year":"1998","unstructured":"Nagy, A. et al. Dissecting the role of N-myc in development using a single targeting vector to generate a series of alleles. Curr. Biol. 8, 661\u2013664 (1998).","journal-title":"Curr. Biol."},{"key":"4932_CR47","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/ng0298-136","volume":"18","author":"EN Meyers","year":"1998","unstructured":"Meyers, E. N., Lewandoski, M. & Martin, G. R. An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination. Nat. Genet. 18, 136\u2013141 (1998).","journal-title":"Nat. Genet."},{"key":"4932_CR48","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/gene.10225","volume":"37","author":"S Hayashi","year":"2003","unstructured":"Hayashi, S., Tenzen, T. & McMahon, A. P. Maternal inheritance of Cre activity in a Sox2Cre deleter strain. genesis 37, 51\u201353 (2003).","journal-title":"genesis"},{"key":"4932_CR49","doi-asserted-by":"publisher","first-page":"20097","DOI":"10.1073\/pnas.1912108116","volume":"116","author":"Y Li","year":"2019","unstructured":"Li, Y. et al. Genetic ablation of acid ceramidase in Krabbe disease confirms the psychosine hypothesis and identifies a new therapeutic target. Proc. Natl. Acad. Sci. USA 116, 20097\u201320103 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"4932_CR50","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.bbadis.2016.11.031","volume":"1863","author":"S Dworski","year":"2017","unstructured":"Dworski, S. et al. Acid Ceramidase Deficiency is characterized by a unique plasma cytokine and ceramide profile that is altered by therapy. Biochimica et. Biophysica Acta (BBA) - Mol. Basis Dis. 1863, 386\u2013394 (2017).","journal-title":"Biochimica et. Biophysica Acta (BBA) - Mol. Basis Dis."},{"key":"4932_CR51","doi-asserted-by":"crossref","first-page":"32","DOI":"10.21037\/atm.2016.09.43","volume":"4","author":"RM Sturm","year":"2016","unstructured":"Sturm, R. M. & Cheng, E. Y. Bladder wall thickness in the assessment of neurogenic bladder: a translational discussion of current clinical applications. Ann. Transl. Med. 4, 32\u201332 (2016).","journal-title":"Ann. Transl. Med"},{"key":"4932_CR52","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1096\/fba.2019-00070","volume":"2","author":"B \u00d6zt\u00fcrk Akcora","year":"2020","unstructured":"\u00d6zt\u00fcrk Akcora, B., Vassilios Gabri\u00ebl, A., Ortiz-Perez, A. & Bansal, R. Pharmacological inhibition of STAT3 pathway ameliorates acute liver injury in vivo via inactivation of inflammatory macrophages and hepatic stellate cells. FASEB BioAdv. 2, 77\u201389 (2020).","journal-title":"FASEB BioAdv."},{"key":"4932_CR53","doi-asserted-by":"publisher","first-page":"5581","DOI":"10.1523\/JNEUROSCI.17-14-05581.1997","volume":"17","author":"GM Samoriski","year":"1997","unstructured":"Samoriski, G. M. & Applegate, C. D. Repeated generalized seizures induce time-dependent changes in the behavioral seizure response independent of continued seizure induction. J. Neurosci. 17, 5581\u20135590 (1997).","journal-title":"J. Neurosci."},{"key":"4932_CR54","doi-asserted-by":"publisher","unstructured":"Ferland, R. J. The repeated flurothyl seizure model in mice. Bio. Protoc. 7 https:\/\/doi.org\/10.21769\/BioProtoc.2309 (2017).","DOI":"10.21769\/BioProtoc.2309"},{"key":"4932_CR55","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/cne.10522","volume":"456","author":"JR Sarna","year":"2003","unstructured":"Sarna, J. R. et al. Patterned Purkinje cell degeneration in mouse models of Niemann-Pick type C disease. J. Comp. Neurol. 456, 279\u2013291 (2003).","journal-title":"J. Comp. Neurol."},{"key":"4932_CR56","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1046\/j.0953-816x.2001.01564.x","volume":"13","author":"J Sarna","year":"2001","unstructured":"Sarna, J., Miranda, S. R. P., Schuchman, E. H. & Hawkes, R. Patterned cerebellar Purkinje cell death in a transgenic mouse model of Niemann Pick type A\/B disease. Eur. J. Neurosci. 13, 1873\u20131880 (2001).","journal-title":"Eur. J. Neurosci."},{"key":"4932_CR57","doi-asserted-by":"publisher","first-page":"8091","DOI":"10.1523\/JNEUROSCI.4173-14.2015","volume":"35","author":"M Praggastis","year":"2015","unstructured":"Praggastis, M. et al. A murine Niemann-Pick C1 I1061T knock-in model recapitulates the pathological features of the most prevalent human disease allele. J. Neurosci. 35, 8091\u20138106 (2015).","journal-title":"J. Neurosci."},{"key":"4932_CR58","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s12017-010-8132-8","volume":"12","author":"Y Chen","year":"2010","unstructured":"Chen, Y., Liu, Y., Sullards, M. C. & Merrill, A. H. An introduction to sphingolipid metabolism and analysis by new technologies. NeuroMolecular Med. 12, 306\u2013319 (2010).","journal-title":"NeuroMolecular Med."},{"key":"4932_CR59","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0022-2275(20)39619-X","volume":"6","author":"JS O\u2019Brien","year":"1965","unstructured":"O\u2019Brien, J. S. & Sampson, E. L. Lipid composition of the normal human brain: gray matter, white matter, and myelin. J. Lipid Res. 6, 537\u2013544 (1965).","journal-title":"J. Lipid Res."},{"key":"4932_CR60","doi-asserted-by":"publisher","first-page":"108132","DOI":"10.1016\/j.celrep.2020.108132","volume":"32","author":"D Fitzner","year":"2020","unstructured":"Fitzner, D. et al. Cell-type- and brain-region-resolved mouse brain lipidome. Cell Rep. 32, 108132 (2020).","journal-title":"Cell Rep."},{"key":"4932_CR61","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/jnc.14452","volume":"146","author":"L Novakova","year":"2018","unstructured":"Novakova, L. et al. Sulfatide isoform pattern in cerebrospinal fluid discriminates progressive MS from relapsing-remitting MS. J. Neurochem. 146, 322\u2013332 (2018).","journal-title":"J. Neurochem."},{"key":"4932_CR62","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/brain\/124.1.154","volume":"124","author":"GJ Nijeholt","year":"2001","unstructured":"Nijeholt, G. J. et al. Post-mortem high-resolution MRI of the spinal cord in multiple sclerosis: a correlative study with conventional MRI, histopathology and clinical phenotype. Brain 124, 154\u2013166 (2001).","journal-title":"Brain"},{"key":"4932_CR63","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.nicl.2018.03.029","volume":"18","author":"E Calabrese","year":"2018","unstructured":"Calabrese, E. et al. Postmortem diffusion MRI of the entire human spinal cord at microscopic resolution. Neuroimage Clin. 18, 963\u2013971 (2018).","journal-title":"Neuroimage Clin."},{"key":"4932_CR64","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/brain\/awy338","volume":"142","author":"Y You","year":"2019","unstructured":"You, Y. et al. Demyelination precedes axonal loss in the transneuronal spread of human neurodegenerative disease. Brain 142, 426\u2013442 (2019).","journal-title":"Brain"},{"key":"4932_CR65","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0002-9440(10)64537-3","volume":"157","author":"B Kornek","year":"2000","unstructured":"Kornek, B. et al. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am. J. Pathol. 157, 267\u2013276 (2000).","journal-title":"Am. J. Pathol."},{"key":"4932_CR66","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.pediatrneurol.2009.08.011","volume":"42","author":"S Mar","year":"2010","unstructured":"Mar, S. & Noetzel, M. Axonal damage in leukodystrophies. Pediatr. Neurol. 42, 239\u2013242 (2010).","journal-title":"Pediatr. Neurol."},{"key":"4932_CR67","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1093\/brain\/awn080","volume":"131","author":"KA Irvine","year":"2008","unstructured":"Irvine, K. A. & Blakemore, W. F. Remyelination protects axons from demyelination-associated axon degeneration. Brain 131, 1464\u20131477 (2008).","journal-title":"Brain"},{"key":"4932_CR68","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/metabo11010018","volume":"11","author":"E Lecommandeur","year":"2020","unstructured":"Lecommandeur, E. et al. Decrease in myelin-associated lipids precedes neuronal loss and glial activation in the CNS of the sandhoff mouse as determined by metabolomics. Metabolites 11, 18 (2020).","journal-title":"Metabolites"},{"key":"4932_CR69","doi-asserted-by":"publisher","first-page":"e18246","DOI":"10.7554\/eLife.18246","volume":"5","author":"F Mei","year":"2016","unstructured":"Mei, F. et al. Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery. Elife 5, e18246 (2016).","journal-title":"Elife"},{"key":"4932_CR70","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/glia.22774","volume":"63","author":"X Wang","year":"2015","unstructured":"Wang, X. et al. Macrophages in spinal cord injury: phenotypic and functional change from exposure to myelin debris. Glia 63, 635\u2013651 (2015).","journal-title":"Glia"},{"key":"4932_CR71","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41593-020-00770-9","volume":"24","author":"CE Dorrier","year":"2021","unstructured":"Dorrier, C. E. et al. CNS fibroblasts form a fibrotic scar in response to immune cell infiltration. Nat. Neurosci. 24, 234\u2013244 (2021).","journal-title":"Nat. Neurosci."},{"key":"4932_CR72","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.3389\/fimmu.2020.01394","volume":"11","author":"N D\u2019Ambrosi","year":"2020","unstructured":"D\u2019Ambrosi, N. & Apolloni, S. Fibrotic scar in neurodegenerative diseases. Front Immunol. 11, 1394\u20131394 (2020).","journal-title":"Front Immunol."},{"key":"4932_CR73","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1172\/JCI10203","volume":"106","author":"M Shibata","year":"2000","unstructured":"Shibata, M. et al. Caspases determine the vulnerability of oligodendrocytes in the ischemic brain. J. Clin. Invest 106, 643\u2013653 (2000).","journal-title":"J. Clin. Invest"},{"key":"4932_CR74","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1471-4159.2008.05566.x","volume":"107","author":"E Dominguez","year":"2008","unstructured":"Dominguez, E., Rivat, C., Pommier, B., Mauborgne, A. & Pohl, M. JAK\/STAT3 pathway is activated in spinal cord microglia after peripheral nerve injury and contributes to neuropathic pain development in rat. J. Neurochem. 107, 50\u201360 (2008).","journal-title":"J. Neurochem."},{"key":"4932_CR75","doi-asserted-by":"publisher","first-page":"7231","DOI":"10.1523\/JNEUROSCI.1709-08.2008","volume":"28","author":"JE Herrmann","year":"2008","unstructured":"Herrmann, J. E. et al. STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J. Neurosci. 28, 7231\u20137243 (2008).","journal-title":"J. Neurosci."},{"key":"4932_CR76","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s13023-020-01659-3","volume":"16","author":"A Bley","year":"2021","unstructured":"Bley, A. et al. The natural history of Canavan disease: 23 new cases and comparison with patients from literature. Orphanet J. Rare Dis. 16, 227\u2013227 (2021).","journal-title":"Orphanet J. Rare Dis."},{"key":"4932_CR77","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0005-2736(00)00210-8","volume":"1469","author":"S Sonnino","year":"2000","unstructured":"Sonnino, S. & Chigorno, V. Ganglioside molecular species containing C18- and C20-sphingosine in mammalian nervous tissues and neuronal cell cultures. Biochimica et. Biophysica Acta (BBA) - Rev. Biomembranes 1469, 63\u201377 (2000).","journal-title":"Biochimica et. Biophysica Acta (BBA) - Rev. Biomembranes"},{"key":"4932_CR78","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.1096\/fj.201902391R","volume":"34","author":"R Vutukuri","year":"2020","unstructured":"Vutukuri, R. et al. S1P d20:1, an endogenous modulator of S1P d18:1\/S1P2-dependent signaling. FASEB J. 34, 3932\u20133942 (2020).","journal-title":"FASEB J."},{"key":"4932_CR79","first-page":"165","volume":"30","author":"G Tredici","year":"1998","unstructured":"Tredici, G., Buccellato, F. R., Cavaletti, G. & Scalabrino, G. Subacute combined degeneration in totally gastrectomized rats: an ultrastructural study. J. Submicrosc. Cytol. Pathol. 30, 165\u2013173 (1998).","journal-title":"J. Submicrosc. Cytol. Pathol."},{"key":"4932_CR80","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1007\/s00586-014-3191-4","volume":"23","author":"HY Sun","year":"2014","unstructured":"Sun, H. Y., Lee, J. W., Park, K. S., Wi, J. Y. & Kang, H. S. Spine MR imaging features of subacute combined degeneration patients. Eur. Spine J. 23, 1052\u20131058 (2014).","journal-title":"Eur. Spine J."},{"key":"4932_CR81","unstructured":"Qudsiya, Z. & De Jesus, O. In StatPearls (2021)."},{"key":"4932_CR82","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.mayocpiqo.2019.03.002","volume":"3","author":"BHR Wolffenbuttel","year":"2019","unstructured":"Wolffenbuttel, B. H. R., Wouters, H. J. C. M., Heiner-Fokkema, M. R. & van der Klauw, M. M. The Many Faces of Cobalamin (Vitamin B(12)) Deficiency. Mayo Clin. Proc. Innov. Qual. Outcomes 3, 200\u2013214 (2019).","journal-title":"Mayo Clin. Proc. Innov. Qual. Outcomes"},{"key":"4932_CR83","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nrgastro.2012.76","volume":"9","author":"MJ Nielsen","year":"2012","unstructured":"Nielsen, M. J., Rasmussen, M. R., Andersen, C. B. F., Nex\u00f8, E. & Moestrup, S. K. Vitamin B12 transport from food to the body\u2019s cells\u2014a sophisticated, multistep pathway. Nat. Rev. Gastroenterol. Hepatol. 9, 345\u2013354 (2012).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"4932_CR84","doi-asserted-by":"publisher","first-page":"232640981769235","DOI":"10.1177\/2326409817692359","volume":"5","author":"L Hannibal","year":"2017","unstructured":"Hannibal, L. et al. Hampered Vitamin B12 metabolism in Gaucher disease. J. Inborn Errors Metab. Screen. 5, 2326409817692359 (2017).","journal-title":"J. Inborn Errors Metab. Screen."},{"key":"4932_CR85","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/0002-9343(94)90149-X","volume":"96","author":"DG Savage","year":"1994","unstructured":"Savage, D. G., Lindenbaum, J., Stabler, S. P. & Allen, R. H. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am. J. Med. 96, 239\u2013246 (1994).","journal-title":"Am. J. Med"},{"key":"4932_CR86","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1007\/s00415-009-0812-7","volume":"255","author":"UK Misra","year":"2008","unstructured":"Misra, U. K., Kalita, J., Kumar, G. & Kapoor, R. Bladder dysfunction in subacute combined degeneration. J. Neurol. 255, 1881\u20131888 (2008).","journal-title":"J. Neurol."},{"key":"4932_CR87","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1586\/14737175.9.3.331","volume":"9","author":"PA McCombe","year":"2009","unstructured":"McCombe, P. A., Gordon, T. P. & Jackson, M. W. Bladder dysfunction in multiple sclerosis. Expert Rev. Neurotherapeutics 9, 331\u2013340 (2009).","journal-title":"Expert Rev. Neurotherapeutics"},{"key":"4932_CR88","first-page":"85","volume":"7","author":"WA Taweel","year":"2015","unstructured":"Taweel, W. A. & Seyam, R. Neurogenic bladder in spinal cord injury patients. Res Rep. Urol. 7, 85\u201399 (2015).","journal-title":"Res Rep. Urol."},{"key":"4932_CR89","doi-asserted-by":"publisher","first-page":"4424","DOI":"10.1016\/S0021-9258(17)41797-2","volume":"269","author":"S Sato","year":"1994","unstructured":"Sato, S. & Hughes, R. C. Regulation of secretion and surface expression of Mac-2, a galactoside-binding protein of macrophages. J. Biol. Chem. 269, 4424\u20134430 (1994).","journal-title":"J. Biol. Chem."},{"key":"4932_CR90","doi-asserted-by":"publisher","unstructured":"Reichert, F. & Rotshenker, S. Galectin-3 (MAC-2) Controls microglia phenotype whether amoeboid and phagocytic or branched and non-phagocytic by regulating the cytoskeleton. Front. Cel. Neurosci. 13, https:\/\/doi.org\/10.3389\/fncel.2019.00090 (2019).","DOI":"10.3389\/fncel.2019.00090"},{"key":"4932_CR91","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3389\/fncel.2019.00157","volume":"13","author":"F Bonsack","year":"2019","unstructured":"Bonsack, F. & Sukumari-Ramesh, S. Differential cellular expression of galectin\u22121 and galectin-3 after intracerebral hemorrhage. Front Cell Neurosci. 13, 157 (2019).","journal-title":"Front Cell Neurosci."},{"key":"4932_CR92","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s12031-009-9186-7","volume":"39","author":"S Rotshenker","year":"2009","unstructured":"Rotshenker, S. The role of Galectin-3\/MAC-2 in the activation of the innate-immune function of phagocytosis in microglia in injury and disease. J. Mol. Neurosci. 39, 99\u2013103 (2009).","journal-title":"J. Mol. Neurosci."},{"key":"4932_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00037-1","volume":"8","author":"YM Morizawa","year":"2017","unstructured":"Morizawa, Y. M. et al. Reactive astrocytes function as phagocytes after brain ischemia via ABCA1-mediated pathway. Nat. Commun. 8, 28 (2017).","journal-title":"Nat. Commun."},{"key":"4932_CR94","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/jlb.63.1.108","volume":"63","author":"MN Ajuebor","year":"1998","unstructured":"Ajuebor, M. N. et al. Endogenous monocyte chemoattractant protein-1 recruits monocytes in the zymosan peritonitis model. J. Leukoc. Biol. 63, 108\u2013116 (1998).","journal-title":"J. Leukoc. Biol."},{"key":"4932_CR95","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1084\/jem.20141656","volume":"212","author":"A Lampron","year":"2015","unstructured":"Lampron, A. et al. Inefficient clearance of myelin debris by microglia impairs remyelinating processes. J. Exp. Med. 212, 481\u2013495 (2015).","journal-title":"J. Exp. Med"},{"key":"4932_CR96","first-page":"1","volume":"2","author":"CR Ferreira","year":"2017","unstructured":"Ferreira, C. R. & Gahl, W. A. Lysosomal storage diseases. Transl. Sci. Rare Dis. 2, 1\u201371 (2017).","journal-title":"Transl. Sci. Rare Dis."},{"key":"4932_CR97","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41582-019-0138-8","volume":"15","author":"TB Johnson","year":"2019","unstructured":"Johnson, T. B. et al. Therapeutic landscape for Batten disease: current treatments and future prospects. Nat. Rev. Neurol. 15, 161\u2013178 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"4932_CR98","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1093\/brain\/aws095","volume":"135","author":"EB Vitner","year":"2012","unstructured":"Vitner, E. B., Farfel-Becker, T., Eilam, R., Biton, I. & Futerman, A. H. Contribution of brain inflammation to neuronal cell death in neuronopathic forms of Gaucher\u2019s disease. Brain 135, 1724\u20131735 (2012).","journal-title":"Brain"},{"key":"4932_CR99","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.nmd.2015.09.007","volume":"25","author":"JJ Gan","year":"2015","unstructured":"Gan, J. J. et al. Acid ceramidase deficiency associated with spinal muscular atrophy with progressive myoclonic epilepsy. Neuromuscul. Disord. 25, 959\u2013963 (2015).","journal-title":"Neuromuscul. Disord."},{"key":"4932_CR100","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ymgme.2017.08.006","volume":"122","author":"LA Adang","year":"2017","unstructured":"Adang, L. A. et al. Revised consensus statement on the preventive and symptomatic care of patients with leukodystrophies. Mol. Genet. Metab. 122, 18\u201332 (2017).","journal-title":"Mol. Genet. Metab."},{"key":"4932_CR101","doi-asserted-by":"publisher","first-page":"e60113","DOI":"10.1371\/journal.pone.0060113","volume":"8","author":"DT Kobayashi","year":"2013","unstructured":"Kobayashi, D. T. et al. SMA-MAP: a plasma protein panel for spinal muscular atrophy. PLoS One 8, e60113\u2013e60113 (2013).","journal-title":"PLoS One"},{"key":"4932_CR102","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3390\/brainsci7080103","volume":"7","author":"O Eberhardt","year":"2017","unstructured":"Eberhardt, O. & Topka, H. Myoclonic disorders. Brain Sci. 7, 103 (2017).","journal-title":"Brain Sci."},{"key":"4932_CR103","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1179\/1743132814Y.0000000396","volume":"36","author":"AD Souza","year":"2014","unstructured":"Souza, A. D. & Moloi, M. W. Involuntary movements due to vitamin B12 deficiency. Neurological Res. 36, 1121\u20131128 (2014).","journal-title":"Neurological Res."},{"key":"4932_CR104","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12883-015-0271-y","volume":"15","author":"RA Alroughani","year":"2015","unstructured":"Alroughani, R. A., Ahmed, S. F., Khan, R. A. & Al-Hashel, J. Y. Spinal segmental myoclonus as an unusual presentation of multiple sclerosis. BMC Neurol. 15, 15\u201315 (2015).","journal-title":"BMC Neurol."},{"key":"4932_CR105","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1046\/j.1528-1157.2001.15800.x","volume":"42","author":"RA Marrie","year":"2001","unstructured":"Marrie, R. A. et al. Unusual imaging findings in progressive myoclonus epilepsy. Epilepsia 42, 430\u2013432 (2001).","journal-title":"Epilepsia"},{"key":"4932_CR106","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.seizure.2018.03.015","volume":"57","author":"WT Tian","year":"2018","unstructured":"Tian, W. T. et al. Progressive myoclonus epilepsy without renal failure in a Chinese family with a novel mutation in SCARB2 gene and literature review. Seizure 57, 80\u201386 (2018).","journal-title":"Seizure"},{"key":"4932_CR107","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1750-3639.2011.00481.x","volume":"21","author":"MC Hagen","year":"2011","unstructured":"Hagen, M. C. et al. Encephalopathy with neuroserpin inclusion bodies presenting as progressive myoclonus epilepsy and associated with a novel mutation in the Proteinase Inhibitor 12 gene. Brain Pathol. 21, 575\u2013582 (2011).","journal-title":"Brain Pathol."},{"key":"4932_CR108","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1172\/JCI123959","volume":"129","author":"DC Pant","year":"2019","unstructured":"Pant, D. C. et al. Loss of the sphingolipid desaturase DEGS1 causes hypomyelinating leukodystrophy. J. Clin. Investig. 129, 1240\u20131256 (2019).","journal-title":"J. Clin. Investig."},{"key":"4932_CR109","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1172\/JCI124159","volume":"129","author":"G Karsai","year":"2019","unstructured":"Karsai, G. et al. DEGS1-associated aberrant sphingolipid metabolism impairs nervous system function in humans. J. Clin. Investig. 129, 1229\u20131239 (2019).","journal-title":"J. Clin. Investig."},{"key":"4932_CR110","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1038\/s41431-019-0444-z","volume":"27","author":"V Dolgin","year":"2019","unstructured":"Dolgin, V. et al. DEGS1 variant causes neurological disorder. Eur. J. Hum. Genet. 27, 1668\u20131676 (2019).","journal-title":"Eur. J. Hum. Genet."},{"key":"4932_CR111","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1136\/jmedgenet-2015-103457","volume":"53","author":"S Edvardson","year":"2016","unstructured":"Edvardson, S. et al. Deficiency of the alkaline ceramidase ACER3 manifests in early childhood by progressive leukodystrophy. J. Med Genet 53, 389\u2013396 (2016).","journal-title":"J. Med Genet"},{"key":"4932_CR112","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.expneurol.2008.09.016","volume":"215","author":"D Papandrea","year":"2009","unstructured":"Papandrea, D., Anderson, T. M., Herron, B. J. & Ferland, R. J. Dissociation of seizure traits in inbred strains of mice using the flurothyl kindling model of epileptogenesis. Exp. Neurol. 215, 60\u201368 (2009).","journal-title":"Exp. Neurol."},{"key":"4932_CR113","doi-asserted-by":"crossref","unstructured":"Engel, J. Seizures and epilepsy. Second edition. edn, (Oxford University Press, 2013).","DOI":"10.1093\/med\/9780195328547.001.0001"},{"key":"4932_CR114","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/S1474-4422(04)00880-4","volume":"3","author":"JN Caviness","year":"2004","unstructured":"Caviness, J. N. & Brown, P. Myoclonus: current concepts and recent advances. Lancet Neurol. 3, 598\u2013607 (2004).","journal-title":"Lancet Neurol."},{"key":"4932_CR115","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s11481-007-9066-2","volume":"2","author":"A Jana","year":"2007","unstructured":"Jana, A. & Pahan, K. Oxidative stress kills human primary oligodendrocytes via neutral sphingomyelinase: implications for multiple sclerosis. J. Neuroimmune Pharm. 2, 184\u2013193 (2007).","journal-title":"J. Neuroimmune Pharm."},{"key":"4932_CR116","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1083\/jcb.200307017","volume":"164","author":"J-T Lee","year":"2004","unstructured":"Lee, J.-T. et al. Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway. J. Cell Biol. 164, 123\u2013131 (2004).","journal-title":"J. Cell Biol."},{"key":"4932_CR117","doi-asserted-by":"publisher","first-page":"e0178622","DOI":"10.1371\/journal.pone.0178622","volume":"12","author":"M Chami","year":"2017","unstructured":"Chami, M. et al. Acid sphingomyelinase deficiency enhances myelin repair after acute and chronic demyelination. PLoS One 12, e0178622\u2013e0178622 (2017).","journal-title":"PLoS One"},{"key":"4932_CR118","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00401-012-1014-4","volume":"124","author":"R van Doorn","year":"2012","unstructured":"van Doorn, R. et al. Fingolimod attenuates ceramide-induced blood\u2013brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes. Acta Neuropathologica 124, 397\u2013410 (2012).","journal-title":"Acta Neuropathologica"},{"key":"4932_CR119","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1194\/jlr.RA120000627","volume":"61","author":"DL Davis","year":"2020","unstructured":"Davis, D. L. et al. Dynamics of sphingolipids and the serine palmitoyltransferase complex in rat oligodendrocytes during myelination. J. lipid Res. 61, 505\u2013522 (2020).","journal-title":"J. lipid Res."},{"key":"4932_CR120","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1385\/JMN:15:2:85","volume":"15","author":"ZF Yu","year":"2000","unstructured":"Yu, Z. F. et al. Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal apoptosis. J. Mol. Neurosci. 15, 85\u201397 (2000).","journal-title":"J. Mol. Neurosci."},{"key":"4932_CR121","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/j.1462-5822.2006.00867.x","volume":"9","author":"H Fischer","year":"2007","unstructured":"Fischer, H. et al. Ceramide as a TLR4 agonist; a putative signalling intermediate between sphingolipid receptors for microbial ligands and TLR4. Cell. Microbiol. 9, 1239\u20131251 (2007).","journal-title":"Cell. Microbiol."},{"key":"4932_CR122","doi-asserted-by":"publisher","first-page":"6352","DOI":"10.1523\/JNEUROSCI.0353-16.2016","volume":"36","author":"JS Church","year":"2016","unstructured":"Church, J. S., Kigerl, K. A., Lerch, J. K., Popovich, P. G. & McTigue, D. M. TLR4 Deficiency Impairs Oligodendrocyte Formation in the Injured Spinal Cord. J. Neurosci. 36, 6352\u20136364 (2016).","journal-title":"J. Neurosci."},{"key":"4932_CR123","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/s41591-021-01346-1","volume":"27","author":"P Mohassel","year":"2021","unstructured":"Mohassel, P. et al. Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis. Nat. Med. 27, 1197\u20131204 (2021).","journal-title":"Nat. Med."},{"key":"4932_CR124","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/ana.10312","volume":"52","author":"RG Cutler","year":"2002","unstructured":"Cutler, R. G., Pedersen, W. A., Camandola, S., Rothstein, J. D. & Mattson, M. P. Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress\u2013induced death of motor neurons in amyotrophic lateral sclerosis. Ann. Neurol. 52, 448\u2013457 (2002).","journal-title":"Ann. Neurol."},{"key":"4932_CR125","doi-asserted-by":"publisher","first-page":"5146","DOI":"10.1074\/jbc.RA118.007291","volume":"294","author":"DL Davis","year":"2019","unstructured":"Davis, D. L., Gable, K., Suemitsu, J., Dunn, T. M. & Wattenberg, B. W. The ORMDL\/Orm-serine palmitoyltransferase (SPT) complex is directly regulated by ceramide: Reconstitution of SPT regulation in isolated membranes. J. Biol. Chem. 294, 5146\u20135156 (2019).","journal-title":"J. Biol. Chem."},{"key":"4932_CR126","doi-asserted-by":"publisher","first-page":"e51067","DOI":"10.7554\/eLife.51067","volume":"8","author":"BA Clarke","year":"2019","unstructured":"Clarke, B. A. et al. The Ormdl genes regulate the sphingolipid synthesis pathway to ensure proper myelination and neurologic function in mice. Elife 8, e51067 (2019).","journal-title":"Elife"},{"key":"4932_CR127","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1042\/bj2050419","volume":"205","author":"T Momoi","year":"1982","unstructured":"Momoi, T., Ben-Yoseph, Y. & Nadler, H. L. Substrate-specificities of acid and alkaline ceramidases in fibroblasts from patients with Farber disease and controls. Biochem J. 205, 419\u2013425 (1982).","journal-title":"Biochem J."},{"key":"4932_CR128","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0005-2760(75)90176-9","volume":"398","author":"M Sugita","year":"1975","unstructured":"Sugita, M., Williams, M., Dulaney, J. T. & Moser, H. W. Ceramidase and ceramide synthesis in human kidney and cerebellum. Description of a new alkaline ceramidase. Biochim Biophys. Acta 398, 125\u2013131 (1975).","journal-title":"Biochim Biophys. Acta"},{"key":"4932_CR129","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1194\/jlr.D600043-JLR200","volume":"48","author":"K Krishnamurthy","year":"2007","unstructured":"Krishnamurthy, K., Dasgupta, S. & Bieberich, E. Development and characterization of a novel anti-ceramide antibody. J. Lipid Res. 48, 968\u2013975 (2007).","journal-title":"J. Lipid Res"},{"key":"4932_CR130","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1194\/jlr.M200241-JLR200","volume":"43","author":"LA Cowart","year":"2002","unstructured":"Cowart, L. A., Szulc, Z., Bielawska, A. & Hannun, Y. A. Structural determinants of sphingolipid recognition by commercially available anti-ceramide antibodies. J. Lipid Res 43, 2042\u20132048 (2002).","journal-title":"J. Lipid Res"},{"key":"4932_CR131","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1194\/jlr.M008748","volume":"51","author":"AY Andreyev","year":"2010","unstructured":"Andreyev, A. Y. et al. Subcellular organelle lipidomics in TLR-4-activated macrophages. J. lipid Res. 51, 2785\u20132797 (2010).","journal-title":"J. lipid Res."},{"key":"4932_CR132","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.plipres.2011.11.001","volume":"51","author":"S Gr\u00f6sch","year":"2012","unstructured":"Gr\u00f6sch, S., Schiffmann, S. & Geisslinger, G. Chain length-specific properties of ceramides. Prog. Lipid Res. 51, 50\u201362 (2012).","journal-title":"Prog. Lipid Res."},{"key":"4932_CR133","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1080\/15384047.2015.1026509","volume":"16","author":"N Cruickshanks","year":"2015","unstructured":"Cruickshanks, N. et al. Differential regulation of autophagy and cell viability by ceramide species. Cancer Biol. Ther. 16, 733\u2013742 (2015).","journal-title":"Cancer Biol. Ther."},{"key":"4932_CR134","doi-asserted-by":"publisher","first-page":"109250","DOI":"10.1016\/j.celrep.2021.109250","volume":"35","author":"S Muralidharan","year":"2021","unstructured":"Muralidharan, S. et al. A reference map of sphingolipids in murine tissues. Cell Rep. 35, 109250 (2021).","journal-title":"Cell Rep."},{"key":"4932_CR135","doi-asserted-by":"publisher","first-page":"170069","DOI":"10.1098\/rsob.170069","volume":"7","author":"ASB Olsen","year":"2017","unstructured":"Olsen, A. S. B. & F\u00e6rgeman, N. J. Sphingolipids: membrane microdomains in brain development, function and neurological diseases. Open Biol. 7, 170069 (2017).","journal-title":"Open Biol."},{"key":"4932_CR136","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/nm.3681","volume":"20","author":"L Mayo","year":"2014","unstructured":"Mayo, L. et al. Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation. Nat. Med. 20, 1147\u20131156 (2014).","journal-title":"Nat. Med."},{"key":"4932_CR137","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1042\/BJ20130825","volume":"456","author":"A Taguchi","year":"2013","unstructured":"Taguchi, A. et al. A symptomatic Fabry disease mouse model generated by inducing globotriaosylceramide synthesis. Biochem J. 456, 373\u2013383 (2013).","journal-title":"Biochem J."},{"key":"4932_CR138","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1093\/hmg\/ddv070","volume":"24","author":"JS Shen","year":"2015","unstructured":"Shen, J. S. et al. Blocking hyperactive androgen receptor signaling ameliorates cardiac and renal hypertrophy in Fabry mice. Hum. Mol. Genet 24, 3181\u20133191 (2015).","journal-title":"Hum. Mol. Genet"},{"key":"4932_CR139","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/jnc.13897","volume":"140","author":"Y Hirahara","year":"2017","unstructured":"Hirahara, Y. et al. Sulfatide species with various fatty acid chains in oligodendrocytes at different developmental stages determined by imaging mass spectrometry. J. Neurochem. 140, 435\u2013450 (2017).","journal-title":"J. Neurochem."},{"key":"4932_CR140","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-58568-5","volume":"10","author":"OM Bhat","year":"2020","unstructured":"Bhat, O. M. et al. Arterial Medial Calcification through Enhanced small Extracellular Vesicle Release in Smooth Muscle-Specific Asah1 Gene Knockout Mice. Sci. Rep. 10, 1645 (2020).","journal-title":"Sci. Rep."},{"key":"4932_CR141","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.1194\/jlr.D010033","volume":"51","author":"C Bedia","year":"2010","unstructured":"Bedia, C., Camacho, L., Abad, J. L., Fabrias, G. & Levade, T. A simple fluorogenic method for determination of acid ceramidase activity and diagnosis of Farber disease. J. Lipid Res. 51, 3542\u20133547 (2010).","journal-title":"J. Lipid Res"},{"key":"4932_CR142","unstructured":"Carson, F. L. & Cappellano, C. H. Histotechnology. (ASCP Press, 2009)."},{"key":"4932_CR143","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671\u2013675 (2012).","journal-title":"Nat. Methods"},{"key":"4932_CR144","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193, 265\u2013275 (1951).","journal-title":"J. Biol. Chem."},{"key":"4932_CR145","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ymgme.2019.08.008","volume":"129","author":"JT Saville","year":"2020","unstructured":"Saville, J. T. & Fuller, M. Sphingolipid dyshomeostasis in the brain of the mouse model of mucopolysaccharidosis type IIIA. Mol. Genet. Metab. 129, 111\u2013116 (2020).","journal-title":"Mol. Genet. Metab."},{"key":"4932_CR146","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/jnc.13976","volume":"141","author":"JT Saville","year":"2017","unstructured":"Saville, J. T., Thai, H. N., Lehmann, R. J., Derrick-Roberts, A. L. & Fuller, M. Subregional brain distribution of simple and complex glycosphingolipids in the mucopolysaccharidosis type I (Hurler syndrome) mouse: impact of diet. J. Neurochem 141, 287\u2013295 (2017).","journal-title":"J. Neurochem"},{"key":"4932_CR147","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1016\/j.ajpath.2016.02.008","volume":"186","author":"J Tinklenberg","year":"2016","unstructured":"Tinklenberg, J. et al. Treatment with ActRIIB-mFc produces myofiber growth and improves lifespan in the Acta1 H40Y murine model of nemaline myopathy. Am. J. Pathol. 186, 1568\u20131581 (2016).","journal-title":"Am. J. Pathol."},{"key":"4932_CR148","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1093\/brain\/awr004","volume":"134","author":"G Ravenscroft","year":"2011","unstructured":"Ravenscroft, G. et al. Mouse models of dominant ACTA1 disease recapitulate human disease and provide insight into therapies. Brain 134, 1101\u20131115 (2011).","journal-title":"Brain"},{"key":"4932_CR149","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","volume":"53","author":"SR Chaplan","year":"1994","unstructured":"Chaplan, S. R., Bach, F. W., Pogrel, J. W., Chung, J. M. & Yaksh, T. L. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods 53, 55\u201363 (1994).","journal-title":"J. Neurosci. Methods"},{"key":"4932_CR150","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1744-8069-8-62","volume":"8","author":"SR Garrison","year":"2012","unstructured":"Garrison, S. R., Kramer, A. A., Gerges, N. Z., Hillery, C. A. & Stucky, C. L. Sickle cell mice exhibit mechanical allodynia and enhanced responsiveness in light touch cutaneous mechanoreceptors. Mol. Pain. 8, 62\u201362 (2012).","journal-title":"Mol. Pain."},{"key":"4932_CR151","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3389\/fninf.2014.00044","volume":"8","author":"BB Avants","year":"2014","unstructured":"Avants, B. B. et al. The Insight ToolKit image registration framework. Front Neuroinform 8, 44 (2014).","journal-title":"Front Neuroinform"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-023-04932-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-023-04932-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-023-04932-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T01:27:06Z","timestamp":1702517226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-023-04932-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,25]]},"references-count":151,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4932"],"URL":"https:\/\/doi.org\/10.1038\/s42003-023-04932-w","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,25]]},"assertion":[{"value":"29 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"560"}}